High shear-dependent loss of membrane integrity and defective platelet adhesion following disruption of the GPIbα-filamin interaction

Blood

Volumn 117, Issue 9, 2011, Pages 2718-2727

  Cranmer, Susan L ^a   Ashworth, Katrina J ^a   Yao, Yu ^a   Berndt, Michael C ^b   Ruggeri, Zaverio M ^c   Andrews, Robert K ^a   Jackson, Shaun P ^a  

^a MONASH UNIVERSITY   (Australia)

^b DUBLIN CITY UNIVERSITY   (Ireland)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2BBETA3 INTEGRIN; FILAMIN A; GLYCOPROTEIN IB ALPHA; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CYTOSKELETON; HUMAN; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; SHEAR RATE; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE MEMBRANE; TRANSGENIC MOUSE; WILD TYPE;

EID: 79953082504     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-07-296194     Document Type: Article

References (37)

1. An X, Mohandas N. Disorders of red cell membrane. Br J Haematol. 2008;141(3):367-375.
2. Fox JE. Identification of actin-binding protein as the protein linking the membrane skeleton to glycoproteins on platelet plasma membranes. J Biol Chem. 1985;260(22):11970-11977. (Pubitemid 16228352)
3. Okita JR, Pidard D, Newman PJ, Montgomery RR, Kunicki TJ. On the association of glycoprotein Ib and actin-binding protein in human platelets. J Cell Biol. 1985;100(1):317-321. (Pubitemid 15151909)
4. Kanaji T, Russell S, Ware J. Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome. Blood. 2002; 100(6):2102-2107. (Pubitemid 35001244)
5. White JG, Burris SM, Hasegawa D, Johnson M. Micropipette aspiration of human blood platelets: a defect in Bernard-Soulier's syndrome. Blood. 1984;63(5):1249-1252. (Pubitemid 14100933)
6. Coller BS. Effects of tertiary amine local anesthetics on von Willebrand factor-dependent platelet function: alteration of membrane reactivity and degradation of GPIb by a calcium-dependent protease(s). Blood. 1982;60(3):731-743. (Pubitemid 12027155)
7. Mistry N, Cranmer SL, Yuan Y, et al. Cytoskeletal regulation of the platelet glycoprotein Ib/V/IX-von Willebrand factor interaction. Blood. 2000;96(10):3480-3489.
8. Coller BS. Inhibition of von Willebrand factor-dependent platelet function by increased platelet cyclic AMP and its prevention by cytoskeleton-disrupting agents. Blood. 1981;57(5):846-855. (Pubitemid 11096474)
9. Nachmias V, Sullender J, Asch A. Shape and cytoplasmic filaments in control and lidocainetreated human platelets. Blood. 1977;50(1):39-53. (Pubitemid 8124749)
10. Jain MK, Eskow K, Kuchibhotla J, Colman RW. Correlation of inhibition of platelet aggregation by phenothiazines and local anesthetics with their effects on a phospholipid bilayer. Thromb Res. 1978;13(6):1067-1075. (Pubitemid 9099812)
11. Cranmer SL, Pikovski I, Mangin P, et al. Identification of a unique filamin A binding region within the cytoplasmic domain of glycoprotein Ibalpha. Biochem J. 2005;387(3):849-858. (Pubitemid 40685721)
12. Nakamura F, Pudas R, Heikkinen O, et al. The structure of the GPIb-filamin A complex. Blood. 2006;107(5):1925-1932. (Pubitemid 43289373)
13. Ware J, Russell SR, Marchese P, Ruggeri ZM. Expression of human platelet glycoprotein Ib alpha in transgenic mice. J Biol Chem. 1993; 268(11):8376-8382. (Pubitemid 23120430)
14. Maxwell MJ, Yuan Y, Anderson KE, Hibbs ML, Salem HH, Jackson SP. SHIP1 and Lyn kinase negatively regulate integrin alpha IIb beta 3 signaling in platelets. J Biol Chem. 2004;279(31):32196-32204. (Pubitemid 39014667)
15. Oltersdorf T, Elmore SW, Shoemaker AR, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 2005;435(7042):677-681. (Pubitemid 40825512)
16. Bergmeier W, Rabie T, Strehl A, et al. GPVI down-regulation in murine platelets through metalloproteinase- dependent shedding. Thromb Haemost. 2004;91(5):951-958. (Pubitemid 38647499)
17. Coller BS, Anderson K, Weisman HF. New antiplatelet agents: platelet GPIIb/IIIa antagonists. Thromb Haemost. 1995;74(1):302-308.
18. Maxwell MJ, Dopheide SM, Turner SJ, Jackson SP. Shear induces a unique series of morphological changes in translocating platelets: effects of morphology on translocation dynamics. Arterioscler Thromb Vasc Biol. 2006;26(3):663-669.
19. Nesbitt WS, Westein E, Tovar-Lopez FJ, et al. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med. 2009;15(6):665-673.
20. Schoenwaelder SM, Yuan Y, Josefsson EC, et al. Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function. Blood. 2009;114(3):663-666.
21. Jackson SP. The growing complexity of platelet aggregation. Blood. 2007;109(12):5087-5095. (Pubitemid 46890522)
22. Dopheide SM, Maxwell MJ, Jackson SP. Shear-dependent tether formation during platelet translocation on von Willebrand factor. Blood. 2002;99(1):159-167.
23. Brinkhous KM, Fricke WA, Read MS. Determinants of von Willebrand factor activity elicited by ristocetin and botrocetin: studies on a human von Willebrand factor-binding antibody. Semin Thromb Hemost. 1985;11(4):337-341. (Pubitemid 16244765)
24. Hartwig JH, Italiano JE Jr. Cytoskeletal mechanisms for platelet production. Blood Cells Mol Dis. 2006;36(2):99-103.
25. Reininger AJ, Heijnen HF, Schumann H, Specht HM, Schramm W, Ruggeri ZM. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood. 2006;107(9):3537-3545.
26. Maxwell MJ, Westein E, Nesbitt WS, Giuliano S, Dopheide SM, Jackson SP. Identification of a 2-stage platelet aggregation process mediating shear-dependent thrombus formation. Blood. 2007;109(2):566-576. (Pubitemid 46105955)
27. Marcus WD, Hochmuth RM. Experimental studies of membrane tethers formed from human neutrophils. Ann Biomed Eng. 2002;30(10):1273-1280.
28. Titushkin I, Cho M. Distinct membrane mechanical properties of human mesenchymal stem cells determined using laser optical tweezers. Biophys J. 2006;90(7):2582-2591.
29. Raucher D, Sheetz MP. Characteristics of a membrane reservoir buffering membrane tension. Biophys J. 1999;77(4):1992-2002. (Pubitemid 29463160)
30. Escolar G, Leistikow E, White JG. The fate of the open canalicular system in surface and suspension-activated platelets. Blood. 1989;74(6):1983-1988. (Pubitemid 19269098)
31. Dong JF, Li CQ, Sae-Tung G, Hyun W, Afshar-Kharghan V, Lopez JA. The cytoplasmic domain of glycoprotein (GP) Ibalpha constrains the lateral diffusion of the GP Ib-IX complex and modulates von Willebrand factor binding. Biochemistry. 1997;36(41):12421-12427. (Pubitemid 27446664)
32. Englund GD, Bodnar RJ, Li Z, Ruggeri ZM, Du X. Regulation of von Willebrand factor binding to the platelet glycoprotein Ib-IX by a membrane skeleton- dependent inside-out signal. J Biol Chem. 2001;276(20):16952-16959.
33. Feng S, Resendiz JC, Lu X, Kroll MH. Filamin A binding to the cytoplasmic tail of glycoprotein Ibalpha regulates von Willebrand factor-induced platelet activation. Blood. 2003;102(6):2122-2129. (Pubitemid 37122389)
34. Schade AJ, Arya M, Gao S, et al. Cytoplasmic truncation of glycoprotein Ib alpha weakens its interaction with von Willebrand factor and impairs cell adhesion. Biochemistry. 2003;42:2245-2251. (Pubitemid 36258699)
35. White JG, Burris SM, Tukey D, Smith C II, Clawson CC. Micropipette aspiration of human platelets: influence of microtubules and actin filaments on deformability. Blood. 1984;64(1):210-214. (Pubitemid 14083877)
36. Ruggeri ZM, Orje JN, Habermann R, Federici AB, Reininger AJ. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood. 2006;108(6):1903-1910. (Pubitemid 44394999)
37. Mailhac A, Badimon JJ, Fallon JT, et al. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis: relative contribution of fibrin(ogen) and platelets. Circulation. 1994;90(2):988-996.